Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.20.1
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Apr. 30, 2019
Summary of Significant Accounting Policies (Textual)        
Impairment $ 400,000      
Goodwill impairment charge 8,996,000 $ 0    
Revenue recognized 3,361,000 0    
Operating lease, impairment loss 300,000      
Impairment of leasehold $ 100,000      
Aggregate equity interest percentage 100.00%      
Cash, uninsured amount $ 600,000   $ 900,000  
Inventory valuation reserves 1,600,000   1,200,000  
Amortization 400,000      
Equity method investments 2,000,000.0      
Equity method investments, upward price adjustment 1,500,000      
Deferred offering costs       $ 3,500,000
Advertising expense $ 1,200,000 $ 1,300,000    
Intraperiod tax allocation 85.00%      
Intraperiod tax allocation remaining after distribution 15.00%      
Bill-And-Hold        
Summary of Significant Accounting Policies (Textual)        
Revenue recognized $ 800,000      
United States        
Summary of Significant Accounting Policies (Textual)        
Goodwill impairment charge $ 8,996,000      
Mint Products | Revenue Benchmark | Product Concentration Risk        
Summary of Significant Accounting Policies (Textual)        
Concentration risk, percentage 0.10% 13.20%    
Airgraft Inc.        
Summary of Significant Accounting Policies (Textual)        
Equity method investment, ownership percentage 1.49%      
Airgraft Inc. | IPO        
Summary of Significant Accounting Policies (Textual)        
Liability for returns included in accrued expenses $ 700,000   600,000  
Other current assets $ 300,000   $ 300,000